Headquartered in Richmnd, VA but having facilities also in Rehovot, Israel, Imunoarray is anchored in iCHIP® , a technology licensed from the Weizmann Institute of Science, ImmunArray is a molecular diagnostics company developing of novel blood based tests to support the diagnosis and management of complex acute and chronic immune-mediated and neurodegenerative diseases. The companys tests measure the repertoire of circulating antibodies to an array of antigens which are printed on ImmunArrays proprietary iCHIP®. This circulating antibody fingerprint is compared to the Companys proprietary database of affected and healthy fingerprints, and proprietary algorithms are used to enable diagnosis of the likelihood of disease or drug response. Repeated testing enable observation of changes in a patients autoantibody signatures over time. The company is organzied around enabling physicians to manage complex autoimmune and neurologic diseases, including traumatic brain injury, by providing them with information from proprietary multi-analyte biomarker-based tests coming out of work unertaken in collaboration with clinicians, partners and medical centers in the USA, Europe and Israel. ImmunArray Ltd. also has worldwide exclusive licenses from Johns Hopkins University in the field of brain injury, Brigham and Womens in Multiple Sclerosis in addition to the firm's own body of filed patents.
